Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans
about
Enzymes of the cyclooxygenase pathways of prostanoid biosynthesisInsights into the prostanoid pathway in the ovary development of the penaeid shrimp Penaeus monodon9alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Thromboxane and the thromboxane receptor in cardiovascular disease.Prostaglandins and inflammation.9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.(5Z,13E)-(15S)-9 alpha,11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2): formation and metabolism by human lung and contractile effects on human bronchial smooth muscle.Isoprostane generation and function.Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine.Concerning prostaglandin D2: forgotten, promiscuous, capricious.Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthaseInhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and MiceAging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disordersStructural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frogThe arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn's disease.Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung.Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans.Metabolic interactions between eicosanoids in blood and vascular cells.A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells.AH6809, a prostaglandin DP-receptor blocking drug on human platelets.Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma.Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2.Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2.Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.PGD2 is reduced to 11-epi-PGF2a by AKRIC3Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves.The aldo-keto reductase superfamily and its role in drug metabolism and detoxification
P2860
Q24630614-BBCE54BA-8A82-4DD3-A570-E679FA569B04Q27304443-89F16F48-2750-477E-BB1A-C206E1658DC1Q28288854-8728BFA3-4186-4B8C-82DC-680C359E2085Q29035699-6ADC08AD-A605-47E1-9DC2-125B10D70C75Q33899567-59910DBB-C830-462F-A731-A45236DA59A3Q34179727-1F35AAC2-3B80-4FD0-B4C7-F025255EE5E4Q34565720-C2013361-81D5-4C64-8188-0A29FCC8CF14Q34586475-501BD6C9-5122-45F7-9B46-4B467E5CB4D6Q35332267-B1FD8B43-0A39-4891-B05B-3608C05C3D54Q35532197-EEDB1BA5-1662-4A25-B6D5-784173266143Q35562980-27BB768D-C7A7-4B56-8976-4F1692E3F8B6Q35594190-8C9F0A43-0D70-484B-8114-CD2073957442Q35677376-E5886FFF-5DA7-4B86-BD9D-C13F40425B90Q35829890-44AD1375-6F80-412C-B46B-54CEB3279646Q36307330-4002A898-61D4-4F02-8C8F-34374D935311Q36860041-15C17250-F393-4656-ADE2-5D7642588E54Q37112098-441DD031-2685-459F-9F63-1C702154D676Q37481617-4C773FA0-50BC-40BB-8C08-1340749AB000Q38221901-38D13685-EB2A-4F7C-B1F7-50FC9E1AE78EQ42711256-C2B7B478-3F00-4910-B3D1-E1E47AAC24A0Q42802279-6EA01EF6-BB1B-4211-ACB3-3BE19930EE0FQ42848943-FA41B6C3-50E1-408F-B1A7-8A0161E182FFQ43658945-F58C462D-2C63-4EC9-915D-0273076468E8Q44776861-73886D07-08B1-474B-9FFB-10D0A8D5B620Q48602031-E1BB959E-0E93-427D-B1C7-8E05B24762C1Q49789514-6DB79869-939B-469C-8436-E9B73B905842Q50293520-7643BD06-79F6-4FEA-AA93-C7D59C1A7DBCQ52935802-42FBDFD0-D5E0-47F2-90C9-DAA16D52C5FAQ54350921-43CBB7A8-F7D5-4A6D-885A-39C1A6F17CEAQ56760512-A9610E95-67A2-4C24-91E8-3983F6AF699A
P2860
Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans
description
1985 nî lūn-bûn
@nan
1985 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
name
Transformation of prostaglandi ...... nzymatically in vivo in humans
@ast
Transformation of prostaglandi ...... nzymatically in vivo in humans
@en
Transformation of prostaglandi ...... nzymatically in vivo in humans
@nl
type
label
Transformation of prostaglandi ...... nzymatically in vivo in humans
@ast
Transformation of prostaglandi ...... nzymatically in vivo in humans
@en
Transformation of prostaglandi ...... nzymatically in vivo in humans
@nl
prefLabel
Transformation of prostaglandi ...... nzymatically in vivo in humans
@ast
Transformation of prostaglandi ...... nzymatically in vivo in humans
@en
Transformation of prostaglandi ...... nzymatically in vivo in humans
@nl
P2860
P3181
P356
P1476
Transformation of prostaglandi ...... nzymatically in vivo in humans
@en
P2093
L J Roberts
T E Liston
P2860
P304
P3181
P356
10.1073/PNAS.82.18.6030
P407
P577
1985-09-01T00:00:00Z